S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
Log in

Aptinyx News Headlines (NASDAQ:APTX)

$3.40
-0.21 (-5.82 %)
(As of 02/24/2020 02:06 PM ET)
Today's Range
$3.36
Now: $3.40
$3.54
50-Day Range
$3.22
MA: $3.86
$5.03
52-Week Range
$2.61
Now: $3.40
$6.00
Volume2,979 shs
Average Volume262,375 shs
Market Capitalization$149.09 million
P/E RatioN/A
Dividend YieldN/A
Beta0.09

Headlines

Aptinyx (NASDAQ APTX) News Headlines

Source:
DateHeadline
2020 Fibromyalgia Pipeline Insight Research Report - Featuring Tonix Pharma, Aptinyx, Syneos Health, Teva Pharma Industries, and Healeon Medical - Yahoo Finance2020 Fibromyalgia Pipeline Insight Research Report - Featuring Tonix Pharma, Aptinyx, Syneos Health, Teva Pharma Industries, and Healeon Medical - Yahoo Finance
finance.yahoo.com - February 19 at 5:36 PM
Aptinyx to Present at Upcoming Investor Conferences - Yahoo FinanceAptinyx to Present at Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - February 19 at 12:36 PM
2020 Fibromyalgia Pipeline Insight Research Report - Featuring Tonix Pharma, Aptinyx, Syneos Health, Teva Pharma Industries, and Healeon Medical - GlobeNewswire2020 Fibromyalgia Pipeline Insight Research Report - Featuring Tonix Pharma, Aptinyx, Syneos Health, Teva Pharma Industries, and Healeon Medical - GlobeNewswire
www.globenewswire.com - February 18 at 2:18 PM
Short Interest in Aptinyx Inc (NASDAQ:APTX) Grows By 13.4%Short Interest in Aptinyx Inc (NASDAQ:APTX) Grows By 13.4%
www.americanbankingnews.com - February 13 at 2:08 PM
$950,000.00 in Sales Expected for Aptinyx Inc (NASDAQ:APTX) This Quarter$950,000.00 in Sales Expected for Aptinyx Inc (NASDAQ:APTX) This Quarter
www.americanbankingnews.com - February 5 at 4:08 AM
 Analysts Expect Aptinyx Inc (NASDAQ:APTX) Will Post Earnings of -$0.59 Per Share Analysts Expect Aptinyx Inc (NASDAQ:APTX) Will Post Earnings of -$0.59 Per Share
www.americanbankingnews.com - February 3 at 9:48 AM
Aptinyx Inc (NASDAQ:APTX) Given Average Recommendation of "Buy" by AnalystsAptinyx Inc (NASDAQ:APTX) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - January 31 at 1:30 AM
Aptinyx (APTX) Reports Publication of Data in Movement Disorders Demonstrating Reversal of Cognitive Deficits with NYX-458 in Primate Model of Parkinsons Disease - StreetInsider.comAptinyx (APTX) Reports Publication of Data in Movement Disorders Demonstrating Reversal of Cognitive Deficits with NYX-458 in Primate Model of Parkinson's Disease - StreetInsider.com
www.streetinsider.com - January 30 at 6:06 PM
Aptinyx Announces Publication of Data in Movement Disorders Demonstrating Reversal of Cognitive Deficits with NYX-458 in Primate Model of Parkinson’s Disease - Yahoo FinanceAptinyx Announces Publication of Data in Movement Disorders Demonstrating Reversal of Cognitive Deficits with NYX-458 in Primate Model of Parkinson’s Disease - Yahoo Finance
finance.yahoo.com - January 30 at 1:05 PM
Aptinyx Announces Publication of Data in Movement...Aptinyx Announces Publication of Data in Movement...
www.benzinga.com - January 30 at 8:05 AM
Aptinyx Announces Publication of Data in Movement Disorders Demonstrating Reversal of Cognitive Deficits with NYX-458 in Primate Model of Parkinson’s DiseaseAptinyx Announces Publication of Data in Movement Disorders Demonstrating Reversal of Cognitive Deficits with NYX-458 in Primate Model of Parkinson’s Disease
finance.yahoo.com - January 30 at 8:05 AM
New Oriental Education (EDU) Is Up 3.93% in One Week: What You Should Know - NasdaqNew Oriental Education (EDU) Is Up 3.93% in One Week: What You Should Know - Nasdaq
www.nasdaq.com - January 21 at 3:33 PM
Why Sysco (SYY) is a Top Dividend Stock for Your Portfolio - NasdaqWhy Sysco (SYY) is a Top Dividend Stock for Your Portfolio - Nasdaq
www.nasdaq.com - January 21 at 9:01 AM
Are You Looking for a High-Growth Dividend Stock? Regions Financial (RF) Could Be a Great Choice - NasdaqAre You Looking for a High-Growth Dividend Stock? Regions Financial (RF) Could Be a Great Choice - Nasdaq
www.nasdaq.com - January 21 at 9:01 AM
Heres Why Fidelity National Information Services (FIS) is a Great Momentum Stock to Buy - NasdaqHere's Why Fidelity National Information Services (FIS) is a Great Momentum Stock to Buy - Nasdaq
www.nasdaq.com - January 21 at 9:01 AM
Why Aptinyx Stock Soared on Friday - NasdaqWhy Aptinyx Stock Soared on Friday - Nasdaq
www.nasdaq.com - January 21 at 9:01 AM
Should Value Investors Buy MetLife (MET) Stock? - NasdaqShould Value Investors Buy MetLife (MET) Stock? - Nasdaq
www.nasdaq.com - January 20 at 11:30 PM
Is Ladenburg Thalmann (LTS) Stock Undervalued Right Now? - NasdaqIs Ladenburg Thalmann (LTS) Stock Undervalued Right Now? - Nasdaq
www.nasdaq.com - January 20 at 6:30 PM
DQ or KWR: Which Is the Better Value Stock Right Now? - NasdaqDQ or KWR: Which Is the Better Value Stock Right Now? - Nasdaq
www.nasdaq.com - January 20 at 6:30 PM
Are Investors Undervaluing China Automotive Systems (CAAS) Right Now? - NasdaqAre Investors Undervaluing China Automotive Systems (CAAS) Right Now? - Nasdaq
www.nasdaq.com - January 20 at 6:30 PM
Are Investors Undervaluing International Game Technology (IGT) Right Now? - NasdaqAre Investors Undervaluing International Game Technology (IGT) Right Now? - Nasdaq
www.nasdaq.com - January 20 at 6:30 PM
Are You Looking for a Top Momentum Pick? Why Installed Building Products (IBP) is a Great Choice - NasdaqAre You Looking for a Top Momentum Pick? Why Installed Building Products (IBP) is a Great Choice - Nasdaq
www.nasdaq.com - January 20 at 6:30 PM
PRGO vs. PAHC: Which Stock Should Value Investors Buy Now? - NasdaqPRGO vs. PAHC: Which Stock Should Value Investors Buy Now? - Nasdaq
www.nasdaq.com - January 20 at 1:29 PM
Canadian Stocks Recovering After Weak Start; TSX Hits New High - NasdaqCanadian Stocks Recovering After Weak Start; TSX Hits New High - Nasdaq
www.nasdaq.com - January 20 at 1:29 PM
This is Why Westamerica (WABC) is a Great Dividend Stock - NasdaqThis is Why Westamerica (WABC) is a Great Dividend Stock - Nasdaq
www.nasdaq.com - January 20 at 1:29 PM
New Oriental Education & Technology Group Q2 adjusted earnings Beat Estimates - NasdaqNew Oriental Education & Technology Group Q2 adjusted earnings Beat Estimates - Nasdaq
www.nasdaq.com - January 20 at 1:29 PM
Should Value Investors Buy Arcos Dorados (ARCO) Stock? - NasdaqShould Value Investors Buy Arcos Dorados (ARCO) Stock? - Nasdaq
www.nasdaq.com - January 20 at 1:29 PM
Are Investors Undervaluing Photronics (PLAB) Right Now? - NasdaqAre Investors Undervaluing Photronics (PLAB) Right Now? - Nasdaq
www.nasdaq.com - January 20 at 1:29 PM
Will IBM (IBM) Beat Estimates Again in Its Next Earnings Report? - NasdaqWill IBM (IBM) Beat Estimates Again in Its Next Earnings Report? - Nasdaq
www.nasdaq.com - January 20 at 1:29 PM
BMY or AZN: Which Is the Better Value Stock Right Now? - NasdaqBMY or AZN: Which Is the Better Value Stock Right Now? - Nasdaq
www.nasdaq.com - January 20 at 1:29 PM
Are Investors Undervaluing Golar LNG Partners LP (GMLP) Right Now? - NasdaqAre Investors Undervaluing Golar LNG Partners LP (GMLP) Right Now? - Nasdaq
www.nasdaq.com - January 20 at 1:29 PM
Why Aptinyx Stock Soared on Friday - Motley FoolWhy Aptinyx Stock Soared on Friday - Motley Fool
www.fool.com - January 20 at 1:29 PM
Notable Insider Buys Last Week: Small-Cap Biotechs - Yahoo FinanceNotable Insider Buys Last Week: Small-Cap Biotechs - Yahoo Finance
finance.yahoo.com - January 18 at 11:01 PM
Notable Insider Buys Last Week: Small-Cap BiotechsNotable Insider Buys Last Week: Small-Cap Biotechs
feeds.benzinga.com - January 18 at 5:42 PM
Form SC 13D Aptinyx Inc. Filed by: ADAMS STREET PARTNERS LLC - StreetInsider.comForm SC 13D Aptinyx Inc. Filed by: ADAMS STREET PARTNERS LLC - StreetInsider.com
www.streetinsider.com - January 17 at 7:48 PM
Aptinyx +10.6% after closing offering, insider buys - Seeking AlphaAptinyx +10.6% after closing offering, insider buys - Seeking Alpha
seekingalpha.com - January 16 at 12:42 PM
Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option - Yahoo FinanceAptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option - Yahoo Finance
finance.yahoo.com - January 15 at 3:41 AM
Form 8-K Aptinyx Inc. For: Jan 13 - StreetInsider.comForm 8-K Aptinyx Inc. For: Jan 13 - StreetInsider.com
www.streetinsider.com - January 14 at 10:41 PM
Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ OptionAptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
finance.yahoo.com - January 14 at 5:41 PM
Aptinyx down 18% premarket on pricing equity offeringAptinyx down 18% premarket on pricing equity offering
seekingalpha.com - January 10 at 5:19 PM
Aptinyx Announces Pricing of Public Offering of Common StockAptinyx Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 10 at 5:19 PM
Aptinyx down 17% after hours on equity offeringAptinyx down 17% after hours on equity offering
seekingalpha.com - January 9 at 5:10 PM
Aptinyx Announces Proposed Public Offering of Common StockAptinyx Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 9 at 5:10 PM
Did You Manage To Avoid Aptinyxs (NASDAQ:APTX) Devastating 80% Share Price Drop?Did You Manage To Avoid Aptinyx's (NASDAQ:APTX) Devastating 80% Share Price Drop?
finance.yahoo.com - January 8 at 4:31 PM
Did You Manage To Avoid Aptinyx's (NASDAQ:APTX) Devastating 80% Share Price Drop?Did You Manage To Avoid Aptinyx's (NASDAQ:APTX) Devastating 80% Share Price Drop?
finance.yahoo.com - January 8 at 6:45 AM
Is Aptinyx Inc. (APTX) A Good Stock To Buy?Is Aptinyx Inc. (APTX) A Good Stock To Buy?
finance.yahoo.com - December 16 at 8:20 AM
Aptinyx to Present at 38th Annual J.P. Morgan Healthcare ConferenceAptinyx to Present at 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 12 at 9:40 AM
Aptinyx to Present Preclinical Data Exhibiting Effects of NYX-783 in Models of PTSD and Alcohol Use Disorder at the American College of Neuropsychopharmacology’s Annual MeetingAptinyx to Present Preclinical Data Exhibiting Effects of NYX-783 in Models of PTSD and Alcohol Use Disorder at the American College of Neuropsychopharmacology’s Annual Meeting
finance.yahoo.com - December 9 at 7:59 PM
Aptinyx launches mid-stage NYX-458 studyAptinyx launches mid-stage NYX-458 study
seekingalpha.com - December 5 at 9:52 AM
Aptinyx Initiates Phase 2 Study of NYX-458 in Patients with Mild Cognitive Impairment Associated with Parkinson’s DiseaseAptinyx Initiates Phase 2 Study of NYX-458 in Patients with Mild Cognitive Impairment Associated with Parkinson’s Disease
finance.yahoo.com - December 5 at 9:52 AM
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel